Worries that tumor necrosis factor (TNF) inhibitors may exacerbate or even cause lung disease in patients with rheumatoid ...
4%,路易威登母公司涨超5%,诺和诺德跌超0.8%】周五(1月10日),阿斯麦控股荷兰阿姆斯特丹股价(ASML.NA)收跌1.17%,报725.30欧元,本周累计上涨5.42%。诺和诺德哥本哈根股价(NOVOB.DC)收涨0.37%,报632.30(丹麦克朗),本周累跌0.82%。罗氏控股(ROG.SW)收跌1.69%,本周累涨4.13%;雀巢(NESN.SW)收跌1.44%,本周累跌0.88%; ...
According to the latest study from BCC Research, "Chronic Disease Management: Therapeutics, Device Technologies, and Global Markets," is projected to grow from $726.3 billion in 2024 to $1.1 trillion ...
Emerging Technologies Revolutionize Chronic Disease Management: Insights into Bio-Wearables, Digital Therapeutics, and AI-Driven Solutions BOSTON, Jan. 10, 2025 /PRNewswire/ -- According ...